The CEOs of Anthem, Lilly, Zimmer and Hill-Rom tried to woo investors at the J.P. Morgan Healthcare conference by stressing how they’re broadening business beyond plain-old insurance, pharmaceuticals, implants and hospital beds.
Nearly half of all Hoosier workers covered by employer health plans are now enrolled in high-deductible, consumer-directed health plans, according to a new survey. That means the state is about to pass the point of no return on transforming health care into a real marketplace.
Health-coverage managers are becoming more aggressive in demanding discounts and exclusive deals from drugmakers to drive down the cost of medicine, Eli Lilly and Co.’s diabetes business chief says.
A batch of Cialis pills, purportedly made at a plant in Australia, was banned by the FDA from entering the U.S. after the pills were found to contain the active ingredient for rival drug Viagra. Cialis manufacturer Eli Lilly said it doesn’t make any drugs in Australia.
Since Obamcare was expected to boost insurance coverage nationally by 32 million people, drugmakers like Eli Lilly and Co. stood to benefit. But it’s not working out that way. At least not for Lilly.
The Indianapolis-based drugmaker said its long-term strategy is on track, but predicted sales this year would be $20.3 billion to $20.8 billion, a shade below what Wall Street was expecting.
A division of CVS Pharmacy Inc. said it would consolidate work done at the facility to locations in Littleton, Colorado, and Jackson, Tennessee.
Recognizing that more and more Hoosier patients are trying to shop for health care, the Indiana Hospital Association has created a web tool with price and quality information for all hospitals around the state. But bigger changes to the health care system will be needed before consumers have the kind of information they expect in other industries.
Roughly 4 million uninsured people are expected to pay penalties, and 26 million could qualify for exemptions from a list of more than 30 waivers.
The research is taking place as marijuana is gaining more acceptance in some parts of the nation, with pot now legalized for adult use in Colorado, Washington state, Alaska and Oregon.
The state Medicaid program will pay $24 million more due to the nursing home building boom that occurred in 2014, according to an analysis by accounting firm Myers & Stauffer. The nursing home industry will use that figure to once again argue for halt to new construction.
Eli Lilly and Co. wants to combine Novartis with its own animal health business, Elanco, to create the second-largest animal health company in the U.S.
WellPoint’s stock price rose 53 percent from Sept. 30, 2013—the day before the Obamacare insurance exchanges started up—until Dec. 19, 2014, when the price closed at $127.95.
Zeke Turner, CEO of Carmel-based Mainstreet, stepped up expansion after he beat back a legislative push by nursing home companies to place a moratorium on new construction.
IU Health wants to consolidate its University and Methodist hospitals into one downtown location, a plan that would see one or both facilities close or be converted to another use.
While the state was strong with regards to immunizations, infectious diseases and binge drinking, it still has work to do in physical activity, obesity, and air pollution.
The expansion at Keystone at the Crossing would nearly double the insurance brokerage firm's Indiana workforce to 49.
Five Indianapolis-area hospitals stand to lose more than $7 million in Medicare payments as a penalty for having rates of infections and patient injuries that run higher than most hospitals nationwide.
The award is actually less than a third of what Warsaw-based Zimmer was originally ordered to pay for infringing patents on a lavage device.
Eli Lilly and Co. could pay more than $570 million to French pharmaceutical company Adocia under an agreement to develop a fast-acting insulin that is in the early stages of clinical testing.
